Volatile Molecules for COVID-19: A Pharmacological Strategy Review

A review paper discussing the feasibility of using volatile molecules as a pharmacological strategy against COVID-19. The paper, authored by Cristiano Colalto and published by the British Pharmacological Society, reviews known aerosolized antiviral drugs and volatile molecules. It provides a complete evaluation of volatile molecules for potential clinical use.

Use Cases

• Literature review on volatile molecule properties based on the paper's discussion of vapour pressure and lung exhalation.
• Identifying candidate molecules for COVID-19 therapy based on the described balance between exhalation characteristics and pharmacological action.
• Evaluating drug delivery strategies for pulmonary diseases based on the paper's analysis of reaching the site of action via exhalation.

Strengths

• Authored by a researcher and published by a professional society (British Pharmacological Society).
• Focuses on a specific and novel pharmacological strategy for a major public health issue (COVID-19).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect temporal bias inherent to paperswithcode, focusing on early-pandemic research.

Provenance

Source

paperswithcode

Collection Method

Likely a published academic paper or review article.